UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050601
Receipt number R000057634
Scientific Title Exploratory Study on Changes in Blood and Brain Metabolites Before and After Modified Electroconvulsive Therapy
Date of disclosure of the study information 2023/03/20
Last modified on 2023/03/15 17:54:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative Study of Changes in Metabolites Before and After Modified Electroconvulsive Therapy

Acronym

Comparison of Metabolites Before and After mECT

Scientific Title

Exploratory Study on Changes in Blood and Brain Metabolites Before and After Modified Electroconvulsive Therapy

Scientific Title:Acronym

Exploratory Study on Changes in Metabolites Before and After mECT

Region

Japan


Condition

Condition

schizophrenia, major depression, bipolar disorder, catatonia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze changes in metabolites before and after electroconvulsive therapy using metabolomic analysis and MR spectroscopy, and to identify metabolites associated with therapeutic effects.

Basic objectives2

Others

Basic objectives -Others

Exploratory observational study before and after treatment.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood metabolites and brain metabolites.

Key secondary outcomes

PANSS, HAM-D, MMSE, HDS-R, GAF, DIEPSS, ECT dose, fMRI, NIRS


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Persons undergoing ECT for the purpose of treating depression, bipolar disorder, schizophrenia, or catatonia.

Key exclusion criteria

People with physical diseases that affect blood metabolites, such as kidney or liver disorders.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kazuhiro
Middle name
Last name Suzuki

Organization

Shinshu University

Division name

Department of Community Mental Health

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto, Nagano

TEL

0263372638

Email

kazsuzuki@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Kazuhiro
Middle name
Last name Suzuki

Organization

Shinshu University

Division name

Department of Community Mental Health

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto, Nagano

TEL

0263372638

Homepage URL


Email

kazsuzuki@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University

Institute

Department

Personal name



Funding Source

Organization

Shinshu University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University

Address

3-1-1, Asahi, Matsumoto, Nagano

Tel

0263372638

Email

kazsuzuki@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 03 Month 15 Day

Date of IRB

2021 Year 08 Month 02 Day

Anticipated trial start date

2023 Year 03 Month 20 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Metabolites in blood and brain using MRS


Management information

Registered date

2023 Year 03 Month 15 Day

Last modified on

2023 Year 03 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057634


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name